Farmers from the various unions stage a protest against Haryana Police and Government over the police baton charge on farmers in Karnal. (Photo | PTI) 
India

Farmers' protests on at Karnal as talks with admin fails

Locked in a showdown with the Haryana government over the lathi-charge, the farmers squatted at the gates of the mini-secretariat on Tuesday evening after talks with the local administration failed.

Express News Service

CHANDIGARH: Farmers’ protests have been going on for more than nine months at Singhu and Tikri border near Delhi. Now, Karnal in Haryana is becoming a third protest site, as talks between farmer leaders and district administration remained inconclusive for the second day.

Farmers have been demanding that the district administration suspend Sub Divisional Magistrate Ayush Sinha and register a case against him. Sinha was caught on camera directing policemen to “break the heads” of farmers. 

A large number of farmers from Haryana, Punjab and Uttar Pradesh are now squatting at the gates of the Mini Secretariat in Karnal.

“Talks with officials of the Karnal district administration went on for three hours, but remained inconclusive, as officers are not ready to suspend Ayush Sinha and register a case against him. Thus, now we have decided to continue our protests here. We will protest here till our demands are met. Now, Karnal is another centre of protest like the Delhi borders,” farmer leader Rakesh Tikait said.  “Now we have pitched tents and are ready for the long haul. The district administrations are defending the IAS officer responsible for the lathicharge on farmers,” he said. 

Why the additional declaration linked to Form 6 is facing a legal challenge

SP-Congress alliance faces fresh strain as Akhilesh skips INDIA bloc meet over UP seat-sharing talks

Rahul Gandhi tells CWC to continue 'resistance' against 'match-fixing' of polls through EVM, voters list

Assam Rifles jawan killed in militant attack in Arunachal; security forces intensify ops to arrest killers

SC slams medicine pricing, calls cancer drug’s 10-fold MRP markup ‘carnage’